Skip to main content

About > Laura Magee, PRE-EMPT Vice-Chair

Photo: Laura Magee is pictured left to Ashlata Mallaphur and Geetanjali Katageri.

Laura Magee is a general internist with Royal College of Canada Certification in Internal Medicine and Clinical Pharmacology. She graduated with an MD (Hons) and has her MSc in clinical epidemiology (both University of Toronto) and undertook a second clinical research fellowship (University of Oxford).  Laura joined UBC in 2000 after four years as an Assistant Professor, University of Toronto.  She is appointed to both the Departments of Medicine (Division of General Internal Medicine) and Obstetrics and Gynaecology (Division of Maternal-Fetal Medicine). At UBC (2000-2015), she was a Consultant in Obstetric Medicine, BC Women’s, and a Senior Clinician Scientist at the CFRI, Reproduction and Healthy Pregnancy Cluster. Recently, she was appointed as the first chair of maternal medicine at SGUL and first dedicated obstetric physician at St George’s NHS Trust.

Laura is focussed on medical complications of pregnancy and the hypertensive disorders of pregnancy in particular, clinical epidemiology (MSc), clinical pharmacology and reproductive toxicology. She is the PI of the CIHR-funded national and international projects, including the CHIPS Trial (Control of Hypertension In Pregnancy Study; published in NEJM), its follow-up study CHIPS-Child, knowledge translation of MgSO4 for fetal neuroprotection (MAG-CP), and investigation of serious maternal morbidity. Importantly, she is a co-investigator on PRE-EMPT.

With Peter von Dadelszen, Laura was co-recipient of the ISSHP’s Chesley Award. Also, Laura is president-elect of the both the ISSHP (2016-18) and the International Society of Obstetric Medicine (2018-2022), the first person to hold both positions.

Laura’s number one collaborator in life and research is Peter von Dadelszen, Professor of Obstetrics and Gynaecology, SGUL. Laura met Peter in Oxford through their shared work. They have three children whose names are familiar to patients (the ‘EMMA’ clinic), clinical colleagues (the ‘PIERS’ project), and research staff (the planned ‘WILL’ trial). Laura has published over 170 papers since her UBC appointment in 2000.